In basal-like breast cancer, FBP1 expression can be transcriptionally repressed by Snail1 to stimulate glycolysis and confer a metabolic advantage to cancer stem cells [65], and nearly all renal cell carcinomas deplete FBP1 to promote their aggressiveness [66]. Here, FBP1 is linked to cancer.